The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficits.
about
Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistryNeuropharmacological mechanisms underlying the neuroprotective effects of methylphenidateModafinil abrogates methamphetamine-induced neuroinflammation and apoptotic effects in the mouse striatumCocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activationMitochondrial fragmentation is involved in methamphetamine-induced cell death in rat hippocampal neural progenitor cells.Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers.Pharmacological approaches to methamphetamine dependence: a focused review.Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia.A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine.A selective D3 receptor antagonist YQA14 attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in miceHIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomesMethylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and dopamine D2 receptors.Age-dependent differences in dopamine transporter and vesicular monoamine transporter-2 function and their implications for methamphetamine neurotoxicity.Comparison of systemic and local methamphetamine treatment on acetylcholine and dopamine levels in the ventral tegmental area in the mouse.Methylphenidate-induced alterations in synaptic vesicle trafficking and activity.Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.The Basal Ganglia as a Substrate for the Multiple Actions of AmphetaminesS(+)amphetamine induces a persistent leak in the human dopamine transporter: molecular stent hypothesisRole of adenosine receptor subtypes in methamphetamine reward and reinforcement.4-Methylthioamphetamine increases dopamine in the rat striatum and has rewarding effects in vivo.Could Modafinil Prevent Psychostimulant Addiction? An Experimental Study in Rats.The Role of HINT1 in Methamphetamine-Induced Conditioned Place Preference.Attenuated methamphetamine induced neurotoxicity by modafinil administration in mice.Methamphetamine self-administration reduces alcohol consumption and preference in alcohol-preferring P rats.
P2860
Q24601233-F79DA0A1-B3E3-409B-BBC3-F9AB9E43A8AEQ24658233-3C44B7E2-9868-4960-85BD-59F594401ED9Q28484231-3F3E149D-3A3F-4907-B3B7-F1155D9E6518Q28576129-02F5B70C-89D6-4A01-9577-1B6E66D757ABQ33444779-E913D665-363A-40E7-9AE7-2C2184A97E63Q33625390-FA56A473-BB34-4D8B-88A5-F1788807007CQ33906303-6D678566-B13A-4226-9FF6-BDFA7582F062Q34196506-DAB3E3EA-211A-484F-A232-5C0B5FBDA0BBQ34892958-899051A6-B6A8-4A5B-B119-0AEE33457BB4Q36579310-42C86FEC-CF59-47E8-9B62-BFC71CE11BEEQ36944251-9FCCF782-4D6C-4A89-83A3-859DD3A95F2DQ36952043-FE560EF6-C4D7-47B1-9391-27040F5E6432Q37019351-26A90EE8-18D4-4DC3-8C33-E1FC769F8EF1Q37101378-6234668D-8056-4C11-A79A-E89458889847Q37183883-AFD2E8AD-3D81-41DE-8BED-C122889FF929Q37789757-CB47A463-E614-4871-BC07-7E6EBA4E5F8AQ37909050-A9095660-EAD2-4E18-AA2B-A4FB5995C316Q42283745-5445259A-79C3-4698-ACE4-F8F4DD5AA408Q43047681-7E208194-B193-4320-9326-10C53D60C687Q43964442-A0E97E05-2E9F-47B3-9766-AF0F24CA31E2Q46350383-347A7624-C9F2-4B18-A4BE-6A1C0153760EQ47900550-3BDCAE01-96E0-49F0-94C6-7AAF17F85C15Q48302473-EFE8FCE6-9731-4C22-B6E3-87C3A2DF947DQ49509783-CB24937A-6C16-4B2A-A60B-A69DF771804C
P2860
The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficits.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The role of the plasmalemmal d ...... induced dopaminergic deficits.
@ast
The role of the plasmalemmal d ...... induced dopaminergic deficits.
@en
type
label
The role of the plasmalemmal d ...... induced dopaminergic deficits.
@ast
The role of the plasmalemmal d ...... induced dopaminergic deficits.
@en
prefLabel
The role of the plasmalemmal d ...... induced dopaminergic deficits.
@ast
The role of the plasmalemmal d ...... induced dopaminergic deficits.
@en
P2093
P2860
P1476
The role of the plasmalemmal d ...... induced dopaminergic deficits.
@en
P2093
Annette E Fleckenstein
Glen R Hanson
Trent J Volz
P2860
P304
P356
10.1111/J.1471-4159.2006.04419.X
P407
P577
2007-01-23T00:00:00Z